General Information of Drug (ID: DMEJOPL)

Drug Name
2,2-bipyridyl derivative 5 Drug Info
Synonyms PMID25468267-Compound-21
Cross-matching ID
TTD Drug ID
DMEJOPL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
N-oxalylglycine derivative 2 DMDJC96 N. A. N. A. Patented [1]
Pyridine-2,4-dicarboxylic acid derivative 1 DMZSTCQ N. A. N. A. Patented [1]
Hydroxamate analog 3 DMDQYJ1 N. A. N. A. Patented [1]
PMID25468267-Compound-51 DMNPC0H N. A. N. A. Patented [1]
PMID25468267-Compound-54 DMI93AX N. A. N. A. Patented [1]
N-oxalylglycine derivative 3 DMQF0RY N. A. N. A. Patented [1]
PMID25468267-Compound-48 DMBPT9Z N. A. N. A. Patented [1]
Pyridine-2,4-dicarboxylic acid derivative 2 DMGCMF5 N. A. N. A. Patented [1]
Pyridine-2,4-dicarboxylic acid derivative 3 DMCUP4L N. A. N. A. Patented [1]
PMID25468267-Compound-53 DMONWYI N. A. N. A. Patented [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Lysine-specific demethylase 4 (KDM4) TT0RGE9 NOUNIPROTAC Inhibitor [1]

References

1 KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44.